Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-003219-22Phase 4Completed
Phase 4, randomised, open-label trial of sertraline in obsessive compulsive disorder (OCD) (3 arms), sponsored by Hertfordshire Partnership University NHS Foundation Trust. Primary endpoints: Feasibility of conducting a larger randomized trial and Variation in Yale-Brown Obsessive Compulsive Scale score. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-003219-22.